Colin Shannon, President & CEO at PRA Health Sciences, Inc. (PRAH), sold 50,000 shares at $64.00 ($3.2M) on 2017-03-28, disclosed to the SEC on 2017-03-30.
Open-market sale of $3.2M PRAH by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRAH | SELL | 2021-06-17 | $62.9M | — | Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |